- Home
- IMA vs IPWR Comparison
IMA vs IPWR Comparison
Compare IMA & IPWR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | IMA | IPWR |
|---|---|---|
| Founded | 2019 | 2007 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Industrial Machinery/Components |
| Sector | Health Care | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 66.3M | 65.4M |
| IPO Year | 2021 | 2013 |
Fundamental Metrics
Financial Performance| Metric | IMA | IPWR |
|---|---|---|
| Price | $5.02 | $3.95 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 2 | 1 |
| Target Price | ★ $16.00 | $10.75 |
| AVG Volume (30 Days) | 10.9K | ★ 137.0K |
| Earning Date | 05-15-2026 | 05-14-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $800,000.00 | N/A |
| Revenue This Year | N/A | $2,603.56 |
| Revenue Next Year | N/A | $1,800.00 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $3.94 | $2.62 |
| 52 Week High | $9.10 | $9.30 |
Technical Indicators
Market Signals| Indicator | IMA | IPWR |
|---|---|---|
| Relative Strength Index (RSI) | 45.55 | 39.75 |
| Support Level | $4.73 | $3.31 |
| Resistance Level | $6.13 | $4.44 |
| Average True Range (ATR) | 0.28 | 0.32 |
| MACD | 0.01 | -0.07 |
| Stochastic Oscillator | 50.62 | 12.50 |
Price Performance
Historical ComparisonAbout IMA ImageneBio Inc.
ImageneBio Inc is a clinical-stage biopharmaceutical company developing therapeutics for patients with immunological, autoimmune and inflammatory diseases. The company's flagship asset, IMG-007, is a non-depleting anti-OX40 monoclonal antibody that binds specifically to OX40 receptor on activated T cells to block receptor binding to OX40 ligand (OX40L). IMG-007 is being developed to potentially treat multiple autoimmune and inflammatory diseases and disorders. The company operates in a single segment.
About IPWR Ideal Power Inc.
Ideal Power Inc is engaged in the development of its broadly patented bidirectional power switches, creating efficient and ecofriendly energy control solutions for electric vehicles, electric vehicle charging, renewable energy, energy storage, UPS / data center, solid-state circuit breaker and other industrial and military applications. The company is focused on its patented Bidirectional, Bipolar Junction Transistor (B-TRAN) semiconductor technology. B-TRAN is a double-sided bidirectional AC switchable to deliver substantial performance improvements over conventional power semiconductors. The primary raw material used in the fabrication of B-TRAN devices is silicon wafers.